InvestSMART

VanEck Global Healthcare Leaders ETF (ASX: HLTH) - Announcements

Current share price for HLTH : $11.230 0.06 (0.53%)+

VanEck Global Healthcare Leaders ETF (HLTH) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. VanEck Global Healthcare Leaders ETF (HLTH) gives investors exposure to a diversified portfolio of the largest international companies from the global healthcare sector. HLTH aims to provide investment returns before fees and other costs which track the performance of the Index.

Latest company announcements for VanEck Global Healthcare Leaders ETF (HLTH)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$52 Issued Units Outstanding as at 30 November 2024 6 Dec 2024 1:23PM $11.460 $11.230 fallen by 2.01%
$52 Issued Units Outstanding as at 31 October 2024 7 Nov 2024 8:49AM $11.520 $11.230 fallen by 2.52%
$52 Issued Units Outstanding as at 30 September 2024 4 Oct 2024 9:15AM $11.070 $11.230 risen by 1.45%
$52 Annual Report FYE 30 June 2024 30 Sep 2024 2:46PM $11.100 $11.230 risen by 1.17%
$52 Replacement Product Disclosure Statement 26 Sep 2024 5:20PM $11.260 $11.230 fallen by 0.27%
$52 Issued Units Outstanding as at 31 August 2024 6 Sep 2024 8:41AM $11.580 $11.230 fallen by 3.02%
$52 Issued Units Outstanding as at 31 July 2024 7 Aug 2024 1:23PM $11.250 $11.230 fallen by 0.18%
$52 Dividend component details 11 Jul 2024 3:43PM $10.580 $11.230 risen by 6.14%
$52 Issued Units Outstanding as at 30 June 2024 4 Jul 2024 5:49PM n/a $11.230 n/a
$52 Dividend Reinvestment Plan Prices 1 Jul 2024 5:10PM $10.600 $11.230 risen by 5.94%
$52 Final Dividend/Distribution for period ending 30 June 2024 28 Jun 2024 8:40AM $10.680 $11.230 risen by 5.15%
$52 Dividend Timetable 24 Jun 2024 10:46AM $10.820 $11.230 risen by 3.79%
$52 Issued Units Outstanding as at 31 May 2024 7 Jun 2024 1:44PM $10.860 $11.230 risen by 3.41%
$52 Issued Units Outstanding as at 30 April 2024 6 May 2024 5:21PM $10.850 $11.230 risen by 3.50%
$52 Issued Units Outstanding as at 31 March 2024 3 Apr 2024 8:27AM $11.430 $11.230 fallen by 1.75%
$52 Half-Year Financial Report 14 Mar 2024 3:21PM $11.290 $11.230 fallen by 0.53%
$52 Indicative dividends calendar for 2024 5 Mar 2024 6:07PM $11.240 $11.230 fallen by 0.09%
$52 Issued Units Outstanding as at 29 February 2024 5 Mar 2024 5:56PM $11.240 $11.230 fallen by 0.09%
$52 Issued Units Outstanding as at 31 January 2024 2 Feb 2024 12:01PM $10.910 $11.230 risen by 2.93%
$52 Issued Units Outstanding as at 31 December 2023 2 Jan 2024 11:04AM $10.350 $11.230 risen by 8.50%
$52 Issued Units Outstanding as at 30 November 2023 5 Dec 2023 8:14AM $9.980 $11.230 risen by 12.53%
$52 Issued Units Outstanding as at 31 October 2023 1 Nov 2023 2:22PM $9.680 $11.230 risen by 16.01%
$52 Issued Units Outstanding as at 30 September 2023 3 Oct 2023 5:18PM $10.090 $11.230 risen by 11.30%
$52 Annual Report FYE 30 June 2023 29 Sep 2023 9:55AM $10.120 $11.230 risen by 10.97%
$52 Issued Units Outstanding as at 31 August 2023 1 Sep 2023 4:24PM $10.450 $11.230 risen by 7.46%

1 - 25 of 78 results

Page 1 of 4

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.